RecruitingNCT02026843
Analysis of Biomarkers From Patients With Chorioretinal Diseases
Sponsor
Kyungpook National University Hospital
Enrollment
100 participants
Start Date
Apr 1, 2012
Study Type
OBSERVATIONAL
Conditions
Summary
This study was conducted to investigate the levels of ocular biomarkers from the patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.
Eligibility
Min Age: 20 YearsMax Age: 80 Years
Inclusion Criteria4
- age over 20 years
- patients requiring ophthalmologic treatments for different degrees of decreasing of visual acuity.
- patients with chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration.
- control patients asking cataract surgery or vitrectomy for posterior segment nonproliferative disorders.
Exclusion Criteria5
- under the age of 20 years
- patients that received any anti-vascular endothelial growth factor agent for proliferative disease before taking sample of aqueous humor
- patients that did not signed the informed consent of the trial
- patients with intraocular inflammations or infections that requiring any pharmaceutical agent
- patients with recent ocular trauma
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGChorioretinal diseases
chorioretinal diseases including diabetic retinopathy, retinal vascular diseases, age-related macular degeneration (dry and wet), and retinal degeneration
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02026843
Related Trials
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT06635148104 locations
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
NCT0744022530 locations
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
NCT074965679 locations
Strategies for Improving Linkage-to-Care After Eye Disease Screening
NCT069435991 location
Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies
NCT036807941 location